Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir
Phase of Trial: Phase II
Latest Information Update: 25 Oct 2017
At a glance
- Drugs Lonafarnib (Primary) ; Ritonavir
- Indications Hepatitis D
- Focus Adverse reactions; Therapeutic Use
- Acronyms LOWR HDV - 3
- 24 Oct 2017 Results of dynamic modelling presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases.
- 23 Oct 2017 Dynamic modeling data presented at the American Association for the Study of Liver Diseases (AASLD) 2017, according to an Eiger BioPharmaceuticals Inc. media release.
- 02 Oct 2017 According to an Eiger BioPharmaceuticals, Inc. media release, study and mathematical modeling designed to inform next steps in clinical development will be presented at the American Association for the Study of Liver Diseases (AASLD) 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History